601 Duboce Avenue, San Francisco, CA, 94117 · (415) 600-6000
Beds
105
FY 2025
Star rating
3 of 5
Patient survey: 3 of 5
Net patient revenue
$302.8M
FY 2025
Net income
$52.1M
Patient care margin 14.5%
Discharges
3,764
Occupancy 42.7%
Clinicians
891
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $302.8M | $258.8M | 14.5% | $52.1M | 3,764 | $4.3M | 29.8% | 4.9% |
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
| Death rate for heart failure patients | 10% | US median 11% |
| Hospital-wide death rate within 30 days | 3.8% | US median 3.9% |
| Death rate for pneumonia patients | 15.1% | US median 15.2% |
| Death rate for stroke patients | 10.4% | US median 11.6% |
| Readmission rate for COPD | 19.6% | US median 19.8% |
| Readmission rate for heart failure | 22.1% |
Medicare clinicians who list this hospital, by specialty
Inpatient stays by diagnosis related group (DRG), 2024
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
Medicare clinicians who work here
| 2024 | $274.1M | $229.3M | 16.4% | $50.0M | 3,751 | $6.7M | 26.9% | 5.4% |
| 2023 | $256.0M | $213.8M | 16.5% | $48.5M | 3,668 | $3.6M | 30.7% | 4.3% |
| 2022 | $243.7M | $183.8M | 24.6% | $63.7M | 3,326 | $3.0M | 32.1% | 4.9% |
| 2021 | $218.5M | $159.0M | 27.2% | $63.5M | 3,012 | $3.2M | 30.7% | 5.1% |
| 2020 | $190.0M | $156.8M | 17.5% | $41.3M | 2,788 | $5.0M | 31.7% | 7.3% |
| US median 21.3% |
| Readmission rate after hip or knee replacement | 5.5% | US median 5.8% |
| Readmission rate for pneumonia | 16.4% | US median 17.2% |
| Complications after hip or knee replacement | 4.6% | US median 4.1% |
| Serious complications (patient safety composite) | 0.98 | US median 0.96 |
| C. diff intestinal infections (ratio to expected) | 0.19 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.00 | US median 0.48 |
| MRSA bloodstream infections (ratio to expected) | 1.76 | US median 0.60 |
| Catheter urinary tract infections (ratio to expected) | 0.00 | US median 0.40 · better |
| Doctors always communicated well | 79% | US median 79% |
| Nurses always communicated well | 73% | US median 80% |
| Patient survey summary star rating | 3 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 46% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 70% | US median 72% |
| Room and bathroom always clean | 75% | US median 73% |
| Patients who would definitely recommend the hospital | 74% | US median 71% |
| Patients who left the emergency department before being seen | 2% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 160 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 21% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 75% | US median 65% |
| Healthcare workers given the flu vaccine | 82% | US median 79% |
| DRG 064 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC |
| 52 |
| $99,321.54 |
| $20,878.81 |
| $15,695.20 |
| DRG 291 HEART FAILURE AND SHOCK WITH MCC | 35 | $52,715.80 | $13,728.54 | $10,022.34 |
| DRG 603 CELLULITIS WITHOUT MCC | 32 | $34,205.72 | $9,489.72 | $6,446.25 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 31 | $44,308.97 | $10,948.03 | $7,681.44 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 19 | $61,089.26 | $16,622.89 | $12,667.88 |
| DRG 552 MEDICAL BACK PROBLEMS WITHOUT MCC | 17 | $41,177.47 | $10,104.88 | $7,114.44 |
| DRG 641 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC | 17 | $40,592.12 | $8,519.94 | $5,829.71 |
| DRG 025 CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MCC | 15 | $235,216.87 | $43,365.27 | $37,824.45 |
| DRG 392 ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC | 15 | $45,835.93 | $8,466.87 | $5,662.18 |
| DRG 690 KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC | 14 | $39,578.57 | $8,672.00 | $5,985.69 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 13 | $66,293.46 | $17,055.92 | $13,076.55 |
| DRG 023 CRANIOTOMY WITH MAJOR DEVICE IMPLANT OR ACUTE COMPLEX CNS PRINCIPAL DIAGNOSIS WITH MCC O | 12 | $224,510.08 | $55,036.08 | $47,977.83 |
| DRG 193 SIMPLE PNEUMONIA AND PLEURISY WITH MCC | 12 | $41,595.50 | $13,801.42 | $9,867.73 |
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5091 Level 1 Breast/Lymphatic Surgery and Related Procedures | 98 | 93 | $4,296.85 | $2,930.15 |
| APC 5374 Level 4 Urology and Related Services | 82 | 75 | $3,921.92 | $2,629.24 |
| APC 8011 Comprehensive Observation Services | 80 | 76 | $3,078.11 | $2,090.36 |
| APC 5113 Level 3 Musculoskeletal Procedures | 76 | 66 | $3,487.56 | $2,373.24 |
| APC 5375 Level 5 Urology and Related Services | 74 | 73 | $5,813.37 | $3,917.51 |
| APC 5092 Level 2 Breast/Lymphatic Surgery and Related Procedures | 69 | 69 | $7,461.40 | $4,981.95 |
| APC 5373 Level 3 Urology and Related Services | 61 | 61 | $2,280.33 | $1,516.28 |
| APC 5114 Level 4 Musculoskeletal Procedures | 60 | 59 | $8,440.64 | $5,338.75 |
| APC 5112 Level 2 Musculoskeletal Procedures | 44 | 42 | $1,772.83 | $1,196.16 |
| APC 5431 Level 1 Nerve Procedures | 31 | 31 | $2,192.87 | $1,406.61 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 23 | 22 | $1,846.47 | $1,219.56 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 20 | 20 | $3,236.14 | $2,141.49 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. ALNY | 59 | $294K |
| Edwards Lifesciences Corporation EW | 25 | $272K |
| Abbott Laboratories ABT | 13 | $136K |
| Boston Scientific Corporation BSX | 6 | $126K |
| Eli Lilly and Company LLY | 4 | $118K |
| Genzyme Corporation SNY | 4 | $100K |
| Gilead Sciences, Inc. GILD | 11 | $70K |
| Stryker Corporation SYK | 13 | $42K |
| Iovance Biotherapeutics, Inc. IOVA | 1 | $39K |
| ModernaTX, Inc. MRNA | 6 | $38K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
California Pacific Medical Ctr-Davies Campus Hosp is a nonprofit short-term acute care hospital in San Francisco, CA with 105 beds, part of Sutter Health and a 3-star overall rating.
California Pacific Medical Ctr-Davies Campus Hosp in San Francisco, CA has 105 beds (fiscal year 2025 cost report); 125 beds are certified for Medicare. It discharged 3,764 inpatients that year, with 42.7% of its beds in use on average.
In fiscal year 2025 (ending 2025-12-31), California Pacific Medical Ctr-Davies Campus Hosp reported net patient revenue of $302.8M and operating expenses of $258.8M, a margin on patient care of 14.5%. After other income and expenses its net income was $52.1M (16.8% of revenue), so it made a profit that year.
California Pacific Medical Ctr-Davies Campus Hosp is part of Sutter Health, a health system with 25 hospitals based in Sacramento, CA. It is a nonprofit hospital.
California Pacific Medical Ctr-Davies Campus Hosp has an overall rating of 3 out of 5 stars in the official hospital quality ratings. Patients rate it 3 out of 5 stars in the patient survey.
No, California Pacific Medical Ctr-Davies Campus Hosp does not list emergency services.
891 Medicare clinicians list California Pacific Medical Ctr-Davies Campus Hosp as a hospital they work at, most often in Internal Medicine, Obstetrics/Gynecology, Anesthesiology.
In 2024, California Pacific Medical Ctr-Davies Campus Hosp had 427 Medicare inpatient stays in 15 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 90 stays; Medicare paid $20,493.29 per stay on average, compared with $15,524.21 across all hospitals.
In 2025, companies reported $1.4M in payments to California Pacific Medical Ctr-Davies Campus Hosp as a teaching hospital ($78K general and $1.3M for research) from 20 companies.